No abstract

The double layer tablets for aceclofenac can be successfully employed as once-a-day oral-controlled release drug delivery system characterized by initial burst release of aceclofenac for providing the loading dose of drug.

Verapamil was encapsulated with ethylcellulose (EC) and cellulose acetate (CA) in various ratios of drug and polymer by the hot melt technique and the prepared microcapsules were evaluated for size range, drug content, drug release profiles, and kinetics of drug release. The microcapsules were compressed into tablets to study the variation of drug release between the 2 types of formulations (ie, microcapsules and tablets). The size analysis of prepared microcapsules was done by a standard sieving method and in vitro dissolution studies were carried out in USP XXI dissolution test apparatus in 0.1 N HCl as dissolution media to study the drug release profiles of the microcapsules. Scanning electron microscopy studies were carried out to investigate the surface characteristics of the microcapsules prepared from both type of polymers. Drug release profiles from the compressed non-disintegrating matrix tablets prepared from the microcapsules were also investigated. All the microcapsules were discrete, free flowing, and reproducible with respect to size distribution and drug content. Maximum percentage of the microcapsules belonged to the size range of 35/50. Drug release durations of VERCA1 (drug: CA 3:1), VERCA2 (drug: CA 2:1), and VERCA3 (drug: CA 1:1) microcapsules were extended up to 3, 5, and 6 hours, respectively, and those of VEREC1 (drug: EC 3:1), VEREC2 (drug: EC 2:1), and VEREC3 (drug: EC 1:1) microcapsules were extended up to 4, 5, and 7 hours, respectively. The microcapsules of both types having a drug:polymer ratio of 1:1 had the slowest release rate in their respective categories. The microcapsules were compressed into nondisintegrating matrix tablets. The hardness of the tablets was tested using the Monsanto Hardness Tester and was found to be 6-7 kg/cm. All the tablets contained the drug verapamil within 100% +/- 5%. The drug release data of both the microcapsules and tablets prepared were examined kinetically, and the ideal kinetic model was determined for the drug release. The tablets prepared by compressing the microcapsule formulations were more satisfactory in releasing the drug at a controlled and uniform rate following Higuchian kinetics and the formulations VCACRT3 and VECCRT3 were able to control release of drug up to 12 hours. Thus, it is possible to formulate a single-unit, controlled-release dosage form of verapamil for oral administration at least once every 12 hours using the polymers CA and EC.

Background: The aim of the present investigation was to improve comprehensive analytical method for the assessment of satranidazole in drug and product with simple, economic, sensitive, and reproducible spectrophotometric method. The drug was analyzed in three different methods by using various solvents where satranidazole (STZ) showed different absorbance maxima (s) and sharp peaks in the first order derivative spectra. Beer's law range, correlation coefficient, apparent molar absorptivity, etc., were determined for each solvent using all the three methods. Results: All the results of analysis were found to be satisfactory which was validated statistically for various parameters and by performing recovery studies in accordance with international conference on harmonization (ICH) guidelines. The developed methods were also compared statistically using one way analysis of variance (ANOVA). Conclusion: Three different spectrophotometric methods were developed for satranidazole (STZ) using various inorganic and organic solvents. The analytical methods are found to be simple, sensitive, rapid, specific, and economic, and it can be conveniently employed for the routine analysis, quality control. The sample recoveries from the formulation were in good agreement with its respective label claim.

The present research work involve the development of a bilayer tablet of ciprofloxacin hydrochloride using a superdisintegranting agent (sodium starch glycolate) for the fast releasing layer and hydrophobic polymers like ethyl cellulose, acrycoat L100 and acrycoat S100 for the delayed releasing layer. Ciprofloxacin was used as a model drug. Tablets were prepared by wet granulation method. The prepared bilayer tablets were evaluated for angle of repose, bulk density, tapped density, Carr's index, Hausner's ratio at the precompression stage and thickness variation, weight variation, hardness, friability, drug content, disintegration time, in vitro drug release study at the post compression stage.. In vitro dissolution studies were carried out in a USP 24 apparatus I. In vitro dissolution kinetics followed the Higuchi model via a non-Fickian diffusion controlled release mechanism after the initial burst release. FT-IR studies revealed that there was no interaction between the drug and polymers. Statistical analysis (ANOVA) showed no significant difference in the cumulative amount of drug release after 15 min, but significant difference (p < 0.05) in the amount of drug released after 12 h from optimized formulations was observed. Present research work involves the development of a bilayer tablet of ciprofloxacin hydrochloride using a superdisintegrant for the fast releasing layer and hydrophobic polymers for the delayed releasing layer. There was the initial burst effect from the formulations to provide the loading dose of the drug, followed by sustained release to provide maintenance dose of the drug.